As new evidence emerges regarding foreknowledge of the Covid-19 “pandemic” and the Rishi Sunak Moderna share scandal, questions are being raised about the level of corruption and foreknowledge in the UK. The evidence comes from the files of the Medicines and Healthcare products Regulatory Agency (MHRA) and raises concerns about their financial activities.
The evidence reveals that the MHRA has been covering up their financial activities, specifically related to their use of Government Procurement Cards (GPCs). The GPCs were introduced in 1997 to streamline procurement processes for low-value goods and services. However, the report highlights that misuse of these cards led to reforms in 2011, including the requirement for departments to publish transactions above £500.
The report further reveals that in December 2017, the Crown Commercial Service published a policy stating that all transactions above £500 should be published monthly. However, the data from the MHRA abruptly ceases after September 2019, with no explanation given. This missing data raises concerns about the level of foreknowledge of Covid-19 and the amount of money that is unaccounted for.
The missing data is particularly concerning considering that the MHRA, which is 86% funded by big pharma, went on to authorize highly dangerous vaccines that made manufacturers hundreds of millions of pounds. The missing data raises questions about who was paid off and whether Prime Minister Rishi Sunak was involved. It also raises the very pertinent question of whether the missing payments were related to a vaccine.
In addition to the missing data, the report also highlights other transparency issues within government departments. These include random purchases and unexplained spending, such as the purchase of fine art photographs from The Tate Gallery by Rishi Sunak's Treasury.
The report concludes by calling for urgent legal action and investigations into the missing datasets. The author urges anyone with information or the ability to find the missing datasets to come forward. The need for transparency and accountability in government procurement processes is essential, especially when it comes to the handling of public funds and the authorization of potentially dangerous vaccines.
In conclusion, the evidence of corruption and cover-up within the MHRA raises significant concerns about the level of foreknowledge and financial misconduct related to Covid-19. It is imperative that lawyers and investigators take immediate action to uncover the truth and hold those responsible accountable. The missing datasets and unexplained spending must be thoroughly investigated to ensure transparency and prevent further corruption in the future.
